Hims & Hers Health (HIMS) closed at $19.12, down 0.83% on the session, with price still below its short- and medium-term moving averages. On November 10, Morgan Stanley and Jefferies cut their pric...
HIMS traded at $19.12, near the low end of its daily range of $18.97 to $19.89. That keeps the stock just above immediate support at $18.76 and below the pivot at $19.33, with stronger resistance at $19.68 and $20.25.
The broader setup is still weak. The 7-day SMA is $19.50, while the 20-day and 50-day SMAs sit much higher at $23.97 and $26.99. The 12-day EMA at $21.41 and 26-day EMA at $23.82 point to the same conclusion: price remains below the main trend markers, so the burden is on buyers to show the move can stabilize.
The RSI at 31.04 shows the stock is close to oversold territory, but that alone does not reverse the trend. MACD is negative at -2.4164, and the histogram is essentially flat at -0.0000, which suggests weak momentum rather than a confirmed turn.
The stochastic readings are also low, with %K at 6.91 and %D at 5.53. That fits a stock under pressure rather than one that has already reclaimed control.
Bollinger positioning is the main constructive element in the data. HIMS is near the lower band at $16.69, and %B at 0.1671 shows price sitting close to the bottom of the recent volatility range. ATR(14) is $2.12, which means the stock can still move sharply in either direction.
Source link







